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Abstract
One in 11 Americans has experienced kidney stones, with a 50% average recurrence rate within 5–
10 years. Ultrasonic propulsion (UP) offers a potential method to expel small stones or residual 
fragments before they become a recurrent problem. Reported here are preliminary findings from 
the first investigational use of UP in humans. The device uses a Verasonics ultrasound engine and 
Philips HDI C5-2 probe to generate real-time B-mode imaging and targeted “push” pulses on 
demand. There are three arms of the study: de novo stones, post-lithotripsy fragments, and the 
preoperative setting. A pain questionnaire is completed prior to and following the study. 
Movement is classified based on extent. Patients are followed for 90 days. Ten subjects have been 
treated to date: three de novo, five post-lithotripsy, and two preoperative. None of the subjects 
reported pain associated with the treatment or a treatment related adverse event, beyond the 
normal discomfort of passing a stone. At least one stone was moved in all subjects. Three of five 
post-lithotripsy subjects passed a single or multiple stones within 1–2 weeks following treatment; 
one subject passed two (1–2 mm) fragments before leaving clinic. In the pre-operative studies we 
successfully moved 7 – 8 mm stones. In four subjects, UP revealed multiple stone fragments 
where the clinical image and initial ultrasound examination indicated a single large stone.
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I. Introduction
Current estimates are that 30 million (1 in 11) Americans will experience a kidney stone 
within their lifetime, and up to 50% of new stone formers will have a recurrence, within as 
early as 5 years [1,2]. Stone management carries an annual economic burden of $10B [3], 
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and data suggest the incidence of kidney stones will continue to grow with our increasing 
obesity and diabetes rate, and even climate change [1].
Current minimally invasive treatment options for nephrolithiasis exist and are effective, but 
commonly leave behind residual stones [4]. These residual stones can grow and lead to 
symptomatic stone episodes, and up to 20% require further treatment procedures [5]. Lower 
pole stones are the most problematic with reported clearance rates as low as 35% (average 
65%) [6]. In addition, approximately 10% of passable (< 5 mm) stones are treated 
surgically; these stone are symptomatic and do not pass on their own.
We have proposed using acoustic radiation force to reposition small stones and fragments, 
particularly lower pole calculi, to facilitate their natural passage. The technology, referred to 
as ultrasonic propulsion (UP), has been described previously [7–12]. This includes safety 
and efficacy evaluation in a porcine animal model. This paper reports on the current results 
from the first in human feasibility testing of UP.
II. Materials and Methods
A. Ultrasound System
The UP system (Fig. 1) is essentially a diagnostic ultrasound platform with a power supply 
capable of emitting longer, slightly higher amplitude focused pulses for short durations 
(VDAS, Verasonics Inc., Redmond, WA, USA). The unit has one 12-bit data acquisition 
board, permitting operation of 128 transmit channels and 64 receive channels 
simultaneously. The device is programmed and controlled through a host personal computer 
(HP Z820, Hewlett Packard, Palo Alto, CA, USA) using MATLAB (Mathworks, Waltham, 
MA, USA). A graphical user interface (GUI) is displayed on a touch screen monitor 
allowing easy control of the ultrasound system parameters. The ultrasound image is 
displayed on the same monitor. The system is programmed to work with the ATL HDI C5-2 
(Philips Ultrasound, Andover, MA, USA).
B. Diagnostic Imaging Modes
1) B-mode—B-mode is achieved through a compound (flash) imaging sequence consisting 
of seven plane waves angled evenly from −12° to +12°. The excitation pulse for each wave 
is a single transmit cycle. The VDAS hardware receives on 64 channels simultaneously, so a 
synthetic aperture sequence is used to receive on all 128 elements of the probe.
2) Doppler—The Doppler transmit is a plane wave at an angle of 12° from the probe axis. 
The excitation is a 14 pulse ensemble where each pulse contains three transmit cycles. The 
received Doppler data is processed with color-flow, power, or custom algorithms designed 
to enhance the “twinkling artifact” commonly seen when viewing kidney stones with 
Doppler ultrasound [13–15].
C. Therapy Mode
The custom derived Push sequence was developed and optimized to work with conventional 
imaging probes and provide enough force to move a stone from the lower pole to the urinary 
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pelvic junction. The burst is constructed from of a series of pulses (Figs. 2). Each pulse 
consists of 450 µs of on time followed by 165 µs of off time (73% duty cycle). This is 
repeated 81 times for a total burst duration of 50 ms.
The total length of the Push sequence was established as a balance between utilizing all the 
energy stored in the power supply capacitor, but of short enough duration to fit between two 
imaging frames. On-time was fixed at 450 µs due to a hard-wired limit within the VDAS on 
the maximum number of transmit pulses. The delay of 165 µs was established through 
optimization of the pulse intensity integral, assuming this correlates with the acoustic force 
delivered to the stone.
Acoustic power and intensity were calculated based upon a burst average intensity model. 
Spatial peak pulse average intensity, spatial peak temporal average intensity and thermal 
index were all below the FDA limits for diagnostic ultrasound devices. The peak 
rarefactional pressure was approximately 6 MPa, resulting in a mechanical index near 2.2.
D. System Operation
The same probe is used to both image the kidney and stone, and generate the acoustic 
radiation force to push the stone. A typical treatment involves placing the probe in contact 
with the patient’s skin to image the stone following standard ultrasound imaging procedure. 
The operator identifies the stone location and then targets the stone with the screen cursor 
using either a mouse or by touching directly on the screen. A single Push is activated by the 
push of a mouse button or touch of the screen. The Push sequence is short enough in 
duration that it occurs between two B-mode imaging frames without affecting frame rate, 
giving real-time imaging feedback of stone motion. The Push can be applied to any location 
and any depth within the image, though the effective force varies as a function of target 
location and the force vector is always in the direction of the ultrasound beam axis. A screen 
video capture is occurring over the entire treatment and a 10 frame IQ acquisition is 
occurring with each Push transmit. To prevent overheating of the probe surface, a 
programmed delay occurs after each Push sequence.
E. Human Feasibility Study
This is a 15 subject human feasibility study approved by the FDA through an investigational 
device exemption.
1) Study Population—Three populations were incorporated into the study. A) Subjects 
with de novo, i.e. newly formed, stones < 5 mm. This tests our ability to move stones that 
were potentially attached to the kidney tissue. B) Post lithotripsy patients with stone 
fragments < 5 mm. This tests our ability to manipulate individual loose stone fragments and 
clusters of loose debri. C) Subjects with stones > 5 mm and scheduled for lithotripsy. This 
tests our ability to move large stones. These subjects were treated just prior to their surgery 
to avoid potential complications.
2) Study Protocol—Subjects are screened with B-mode prior to the UP treatment to 
ensure the stone is identifiable, at an appropriate angle for pushing, and no other unforseen 
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complications exist. The subject is asked to fill out a pain questionairre before and after the 
therapy treatment. A maximum of 40 Push attempts are administered at 50 Vp or 90 Vp 
(maximum) electrical drive voltage. Subjects are asked after each of the first three Pushes if 
they experienced any sensations. Subjects are contacted once a week for three weeks 
following treatment for the occurrence of any adverse events and stone passage. Subjects 
receive a follow-up imaging examination 4–6 weeks after treatment and a final check of 
their medical charts is made 90 days after treatment for any treatment related events beyond 
the first three weeks.
III. Results
To date 15 subjects have been consented and ten subjects have undergone the UP study. 
Results are summarized in Table 1.
A. Efficacy
Efficacy is measured by stone movement. This was graded as 1–no movement, 2–shift in 
position < 3 mm or rollback into the same position or 3–displacement to a new location. A 
detailed breakdown for each subject is provided in Table 2. At least one stone was moved in 
all subjects. The greatest number and extent of movement was from the post-lithotripsy 
group. An example is shown in Fig. 1, where a stone fragment was moved along the lower 
pole infundibulum (a) and out of the calyx (b).
Three of the five subjects in the post lithotripsy group passed a stone within 1–2 weeks 
following treatment. One subject passed 2 fragments before leaving clinic (Fig. 2a) and 14 
additional granule size fragments within 1–2 days following clinic (Fig. 2b). A second 
subject passed over 10 granular fragments within few days following treatment and the third 
subject passed at least one, 1–2 mm fragment within 1–2 weeks following treatment. None 
of these subjects had passed a stone within two weeks prior to the treatment. A fourth post 
lithotripsy subject experienced discomfort commonly associated with passing a stone over 
the first few days post treatment, but did not observe a stone being passed.
We had moderate success moving de novo stones and stones > 5 mm. For the de novo 
subjects, there was no means to identify if the stones were attached. The physician did report 
that there was one strongly attached stone in the preoperative case, believed to be the one 
stone we could not move. In four subjects, Pushing revealed a distribution of stone 
fragments where the clinical image and initial ultrasound examination indicated a single 
large stone (Fig. 2). This has potential diagnostic implications for stone management.
B. Safety
None of the subjects reported pain associated with the treatment, just a mild warming of the 
transducer at the peak output power. There have been no unanticipated adverse effects and 
no device related adverse events.
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IV. Conclusion
This is a preliminary report for the ultrasonic propulsion of kidney stones in humans. This 
study has demonstrated the ability to manipulate stones transcutaneously with this 
technology. The therapy treatment for three subjects is potentially clinically significant, as it 
promoted the passage of multiple stone fragments that may have grown into future 
symptomatic stone events. A diagnostic benefit was evident for differentiating several 
passable stones from a single large stone requiring surgery. There have been no reported 
unanticipated adverse events and no device related adverse events. Modification to the 
technology may be need for detaching and moving de novo stones and for moving large 
stones.
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Figure 1. 
Ultrasound image of a kidney and two stones, approximately 2–3 mm, in the lower pole (left 
panel). The two panels on the right show the position of two stones before the application of 
a Push (a), and immediately following the Push (b). One stone (red arrow) is moved up the 
infundibulum.
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Figure 2. 
(a) Two stone fragments passed by a post lithotripsy subject in clinic after the UP treatment. 
(b) 14 fragments passed by a post lithotripsy subject within 1–2 days following UP 
treatment.
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Figure 3. 
Ultrasound image of a kidney and stone (Top). The three panels highlight the section 
surrounding the stone (green box). A single stone observed on ultrasound (a) is seen to be 
multiple stones after delivery of a Push pulse (b). The stone on the left was then pushed out 
of the calyx on subsequent pulses (c).
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TABLE I
Preliminary Summary Results for Ultrasonic Propulsion of Kidney Stones
Population
Group
Total #
Stones
# Stones Moved Stones
Passed
Grade 2 Grade 3
De novo 10 5 1 0
Post lithotripsy* 14 12 10 3 (1–2 mm)
20 (< 1 mm)
Pre-operative 3 2 1 N/A
*
Difficult to establish the total number of fragments pushed as they often occurred in clumps of granules.
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